Technical Analysis for VCNX - Vaccinex, Inc.

Grade Last Price % Change Price Change
grade F 4.72 2.61% 0.12
VCNX closed up 2.61 percent on Thursday, December 13, 2018, on 34 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical VCNX trend table...

Date Alert Name Type % Chg
Dec 13 Slingshot Bearish Bearish Swing Setup 0.00%
Dec 13 Lower Bollinger Band Walk Weakness 0.00%
Dec 13 Wide Bands Range Expansion 0.00%
Dec 13 Lower Bollinger Band Touch Weakness 0.00%
Dec 13 Oversold Stochastic Weakness 0.00%
Dec 12 New 52 Week Closing Low Bearish 2.61%
Dec 12 180 Bearish Setup Bearish Swing Setup 2.61%
Dec 12 Lower Bollinger Band Walk Weakness 2.61%
Dec 12 New 52 Week Low Weakness 2.61%
Dec 12 Stochastic Reached Oversold Weakness 2.61%

Older signals for VCNX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Is VCNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.0
52 Week Low 4.6
Average Volume 5,070
200-Day Moving Average 0.0
50-Day Moving Average 6.1584
20-Day Moving Average 5.6658
10-Day Moving Average 5.3565
Average True Range 0.5529
ADX 24.72
+DI 14.8006
-DI 27.1471
Chandelier Exit (Long, 3 ATRs ) 5.2313
Chandelier Exit (Short, 3 ATRs ) 6.2587
Upper Bollinger Band 6.653
Lower Bollinger Band 4.6786
Percent B (%b) 0.02
BandWidth 34.847683
MACD Line -0.388
MACD Signal Line -0.3242
MACD Histogram -0.0638
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.95
Resistance 3 (R3) 6.06 5.77 5.75
Resistance 2 (R2) 5.77 5.45 5.71 5.68
Resistance 1 (R1) 5.24 5.26 5.51 5.13 5.61
Pivot Point 4.95 4.95 5.08 4.89 4.95
Support 1 (S1) 4.42 4.63 4.69 4.31 3.83
Support 2 (S2) 4.13 4.44 4.07 3.76
Support 3 (S3) 3.60 4.13 3.70
Support 4 (S4) 3.49